2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Oral Session

[O14] Oral Session 14　Gynecologic Cancer
【E】

Sat. Feb 19, 2022 3:00 PM - 4:10 PM Room 5 (Room B-1, 2F, Kyoto International Conference Center)

Chair：Noriyuki Katsumata（Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital ），Keiichi Fujiwara（Department of Gynecologic Oncology, Saitama Medical University International Medical Center）
Discussant：Mayu Yunokawa（Department of Gynecology Oncology and Department of Medical Oncology, Cancer Institute hospital of JFCR）

[O14-2] Tisotumab Vedotin in Japanese Patients With Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 206 Study

○Kan Yonemori1, Yasutoshi Kuboki2, Kosei Hasegawa3, Takashi Iwata4, Hidenori Kato5, Kazuhiro Takehara6, Yasuyuki Hirashima7, Hisamori Kato8, Chaitali Passey9, Jeppe Klint Buchbjerg10, Jeffrey R. Harris Harris9, Camilla Mondrup Andreassen10, Leonardo Nicacio11, Ibrahima Soumaoro9, Keiichi Fujiwara3 (1.National Cancer Center Hospital, 2.National Cancer Center Hospital East, 3.Saitama Medical University International Medical Center, 4.Keio University School of Medicine, 5.National Hospital Organization, Hokkaido Cancer Center, 6.NHO Shikoku Cancer Center, 7.Shizuoka Cancer Center, 8.Kanagawa Cancer Center, 9.Genmab US, Inc., 10.Genmab, 11.Seagen Inc.)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password